DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

    Crohn’s Disease Epidemiology G7, E7 and ROW; Ulcerative Colitis G7, E7 and ROW

    DRG Epidemiology’s global epidemiology forecast for CD & UC offers 10 year (20 years in the G7) epidemiological forecasts for 45 countries, covering 90% of the world’s population for all of the following CD & UC patient populations:

    • Diagnosed prevalent cases
    • Diagnosed prevalent cases of CD by behavior (non-structuring, non-fistulizing; structuring; and penetrating)
    • Diagnosed prevalent cases of UC by extent (ulcerative proctitis; extensive ulcerative colitis; and left sided ulcerative colitis)

    In addition, estimates of the drug-treated prevalent population are also available for United States, France, Germany, Italy, Spain, United Kingdom and Japan.

    DRG Epidemiology’s estimates are presented in DRG’s Insights Platform, allowing the user to easily navigate between world regions and patient populations, as well as download the data in Excel formatted files.

    All of our epidemiological forecasts are accompanied by a transparent description of our forecast methods and data sources, the details of our systematic review underlying each forecast and associated summary evidence tables, and access to the authoring epidemiologist. All epidemiological forecasts may be supplemented with custom deliverables, such as:

    • Chart reviews using DRG’s in-house real world datasets or physician survey data
    • More detailed patient flow models or additional subpopulations or metrics
    • Coverage of countries or extended forecast periods beyond those available